Raksha Jain, MD
Enriched profileProfessor, Department of Internal Medicine, UT Southwestern Medical Center; Medical Director, Adult Cystic Fibrosis Program · The University of Texas Southwestern Medical Center
Raksha Jain is Professor, Department of Internal Medicine, UT Southwestern Medical Center; Medical Director, Adult Cystic Fibrosis Program at The University of Texas Southwestern Medical Center. OpenAlex indexes 160 publications with 7,387 citations (h-index 34); ClinicalTrials.gov lists 5 registered studies with this person as an investigator.
Data verified 14 Sept 2026
Overview
Updated 14 Oct 2026
Raksha Jain, MD, is Professor, Department of Internal Medicine, UT Southwestern Medical Center at The University of Texas Southwestern Medical Center. The public record shows 160 publications with 7,387 citations (h-index 34), centered on Cystic Fibrosis Research Advances, Neonatal Respiratory Health Research, Asthma and respiratory diseases. It also documents an investigator role on 5 registered clinical trials, industry payments reported by 13 companies, 2 NIH-funded awards (2011–2026).
- Most recent indexed publication: 2026 · Annals of the American Thoracic Society
- Top research focus: Cystic Fibrosis Research Advances
- 5 registered trials on ClinicalTrials.gov
- Open Payments reporting from 13 companies
Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 11 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 77.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 14 Oct 2026
Listed as an investigator on 5 registered studies on ClinicalTrials.gov. The most recent:
- Health Outcomes of Parents With Cystic Fibrosis-Aim 2
Sponsor: University of Pittsburgh
- 4D-710 in Adult Patients With Cystic Fibrosis
Sponsor: 4D Molecular Therapeutics
- Prospective Study of Pregnancy in Women With Cystic Fibrosis
Sponsor: Amalia Magaret
Industry payments
Updated 14 Oct 2026
13 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Boehringer Ingelheim International GmbHProgram year20256 payments$14,047openpaymentsdata.cms.gov ↗
- Insmed, Inc.Program year202514 payments
- VERTEX PHARMACEUTICALS INCORPORATEDProgram year20251 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
69.1%Other respiratory system products30.9%Trikafta100%Part D≥14 patientsbeta2-Adrenergic Agonist15.2%Albuterol Sulfate Hfa62%Ventolin Hfa38%Part D<11 patients+ 2 more classes in this area
Metabolism & gastrointestinal
24.7%Antidiarrheal microorganisms13%Zenpep100%Part D<11 patientsBile Acid6.7%Ursodiol100%Part D<11 patients+ 1 more class in this area
Anti-infectives
6.3%Macrolide Antimicrobial6.3%Azithromycin100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 14 Oct 2026
2 NIH research awards on record, funded 2011–2026 per NIH RePORTER. The latest:
- Estrogen-mediated effects on neutrophil function and airway inflammatory response
Ut Southwestern Medical Center
FY2026$554,612R01HL175722 - Estrogen-mediated effects on neutrophil function and airway inflammatory response
Ut Southwestern Medical Center
FY2025$511,097R01HL175722 - Estrogen-mediated effects on neutrophil function and airway inflammatory response
Ut Southwestern Medical Center
FY2024$574,000R01HL175722
Congress activity
Updated 14 Oct 2026
3 congress contributions (2014–2025) across ASTRO, ENDO per OpenAlex. The most recent:
- MON-575 Association of CFRD Development Among Females with CF Who Use Hormonal Contraception
ENDO Annual Meeting
ENDO2025Co-author - Outcomes After IMRT Compared to 3DCRT for Squamous Cell Carcinoma of the Anus
ASTRO Annual Meeting
ASTRO2014Co-author - Quantitative FDG-PET/CT Predicts Local Recurrence and Survival for Squamous Cell Carcinoma of the Anus
ASTRO Annual Meeting
ASTRO2014Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 14 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- The clinical, psychosocial, and economic burden of cystic fibrosis lung disease in the era of CFTR modulator therapy.
Annals of the American Thoracic Society
Review2026 - Addressing Sex as a Biological Variable in Preclinical Models of Lung Disease: An Official American Thoracic Society Research Statement.
American journal of respiratory and critical care medicine
Article2025 - Lentiviral Gene Therapy for Cystic Fibrosis: A Promising Approach and First-in-Human Trial.
American journal of respiratory and critical care medicine
Review2024 - Outcomes in Black People with Cystic Fibrosis: A Registry Analysis.
Annals of the American Thoracic Society
Letter2024 - Impact of Discontinuing Both Hypertonic Saline and Dornase Alfa after Elexacaftor-Tezacaftor-Ivacaftor in Cystic Fibrosis.
Annals of the American Thoracic Society
Clinical Trial2024
Most-cited works
by citation count (OpenAlex)- 01Elexacaftor–Tezacaftor–Ivacaftor for Cystic Fibrosis with a Single Phe508del AlleleArticle2,156 citations2019
- 02
- 03Gender Differences in Outcomes of Patients with Cystic FibrosisArticle206 citations2014
- 04In vivo editing of lung stem cells for durable gene correction in miceArticle167 citations2024
- 05Temporal Relationship between Primary and Motile Ciliogenesis in Airway Epithelial CellsArticle162 citations2010
Network
Updated 14 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 14 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/raksha-jain-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
cff.swoogo.com/researchcon2021/speaker/231937/raksha-jain-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cff.swoogo.com ↗ - Other
profiles.utsouthwestern.edu/profile/19733/raksha-jain.html
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗ - Other
eventscribe.net/2022/nacfcprogram/fsPopup.asp
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →eventscribe.net ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 14 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
- B.S.
Molecular Biology, Massachusetts Institute of Technology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗ - Board Certified
American Board of Internal Medicine, Internal Medicine, Pulmonary Disease, and Critical Care Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
Editorial & leadership roles
journal and society appointments- Fellow
American Thoracic Society (ATSF)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →site.thoracic.org ↗ - Chair
Sexual Health, Reproduction, and Gender Research Working Group, Cystic Fibrosis Foundation Therapeutics Development Network
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗ - Member
American Thoracic Society
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗ - Member
American College of Chest Physicians
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗ - Member
Texas Medical Association
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗ - Member
Dallas County Medical Society
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗ - Member
Society for Women's Health Research
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗ - Member
American Medical Association
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →site.thoracic.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
- Willis C. Maddrey
M.D. Distinguished Professorship in Clinical Science
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Robert Toto, MD
The University of Texas Southwestern Medical Center
Jing Chen, MD
The University of Texas Southwestern Medical Center
John Battaile, MD
The University of Texas Southwestern Medical Center
Rafael Cires-Drouet, MD
The University of Texas Southwestern Medical Center
Fernando Martinez, MD
University of Massachusetts Chan Medical School
David Gozal, MD
Marshall University
Ronald Crystal, MD
Weill Cornell Medicine
Bartolome Celli, MD
Brigham and Women's Hospital